What are the guidelines for infusion rates in ICU settings?

Infusion Rate Guidelines in ICU Settings

Insulin Infusion for Hyperglycemia Management

For critically ill ICU patients requiring insulin infusion, initiate therapy when blood glucose exceeds 180 mg/dL, targeting glucose levels between 140-180 mg/dL, with monitoring every 1-2 hours until stable, then every 4 hours thereafter. 1, 2

Insulin Administration Protocol

• Use continuous intravenous insulin infusion (1 unit/mL concentration) as the preferred method for glycemic control in ICU patients, as IV insulin's short half-life (<15 minutes) allows rapid dose adjustments 1, 2
• Prime new tubing with a 20-mL waste volume before initiating infusion 1
• Avoid subcutaneous insulin in critically ill patients, particularly during hypotension or shock, due to unpredictable absorption 2
• Monitor blood glucose every 1-2 hours until glucose values and insulin infusion rates stabilize, then every 4 hours 1
• Use arterial blood rather than capillary blood for point-of-care testing when arterial catheters are available 1

Pediatric Considerations

• In pediatric ICU patients, treat repetitive blood glucose levels >10 mmol/L (180 mg/dL) with continuous insulin infusion 1
• For neonates in NICU, use insulin therapy when glucose adaptation has been insufficient for levels >180 mg/dL 1
• Avoid hyperglycemia >8 mmol/L (145 mg/dL) in both pediatric and neonatal ICU patients due to increased morbidity and mortality 1

Critical Safety Parameters

• Avoid glucose targets below 110 mg/dL (6.1 mmol/L) due to increased hypoglycemia risk without additional clinical benefit 2
• Prevent hypoglycemia <2.5 mmol/L (45 mg/dL) in all ICU patients, as severe hypoglycemia (<40 mg/dL) is associated with cognitive impairment and increased mortality 1, 2
• Monitor potassium levels carefully during insulin therapy, as hypokalemia is common during treatment 2

---

Fluid Resuscitation Rates in Septic Shock

For septic shock patients, administer initial fluid resuscitation at rates of 0.25-0.50 ml/kg/min (completing the initial 30 ml/kg within the first 2 hours) to achieve early shock reversal and lower mortality. 3

Initial Resuscitation Phase

• Begin with isotonic crystalloids (preferably Ringer's lactate) at 5-10 ml/kg/h for the first 24 hours in severe sepsis and acute pancreatitis 1, 4
• Fluid administration should be aggressive in the first hours but discontinued or significantly reduced after 24-48 hours 1, 4
• Faster fluid resuscitation rates (≥0.5 ml/kg/min) are associated with shorter time to shock reversal compared to slower rates (<0.17 ml/kg/min) 3
• Complete the initial 30 ml/kg fluid bolus within 2 hours when possible, as rates ≥0.25 ml/kg/min correlate with decreased 28-day mortality 3

Monitoring and Titration

• Use frequent reassessment of hemodynamic status to guide fluid administration and avoid fluid overload 1, 5
• Monitor hematocrit, blood urea nitrogen, creatinine, and lactate as laboratory markers of adequate tissue perfusion 1
• Target urinary output, reversal of tachycardia and hypotension, and improvement of laboratory markers as resuscitation endpoints 1, 4
• For hemodynamically unstable septic patients, use continuous renal replacement therapies to facilitate fluid balance management 1

Restrictive vs. Liberal Strategies

• Recent evidence shows no significant mortality difference between restrictive (prioritizing vasopressors with lower fluid volumes) and liberal (prioritizing higher fluid volumes before vasopressors) strategies in sepsis-induced hypotension 6
• The restrictive approach resulted in approximately 2,134 ml less fluid administered over 24 hours but required earlier and more prevalent vasopressor use 6

---

Vasopressor Infusion Rates

For norepinephrine infusion in acute hypotensive states, start at 2-3 ml/min (8-12 mcg/min of base) after diluting 4 mg in 1,000 mL of 5% dextrose, then titrate to maintain systolic blood pressure 80-100 mmHg. 7

Norepinephrine Administration

• Dilute norepinephrine (4 mg/4 mL vial) in 1,000 mL of 5% dextrose-containing solution (final concentration: 4 mcg/mL) 7
• Never administer in saline solution alone, as dextrose-containing fluids protect against significant loss of potency due to oxidation 7
• Initial dose: 2-3 mL/min (8-12 mcg/min of base), then adjust to establish low normal blood pressure 7
• Average maintenance dose: 0.5-1 mL/min (2-4 mcg/min of base) 7
• In previously hypertensive patients, raise blood pressure no higher than 40 mmHg below pre-existing systolic pressure 7

Administration Technique

• Insert plastic IV catheter through suitable bore needle well advanced centrally into vein 7
• Use IV drip chamber or metering device for accurate flow rate estimation 7
• Reduce infusion gradually when discontinuing; avoid abrupt withdrawal 7
• Correct occult blood volume depletion if high doses are required, as doses up to 68 mg base daily may be necessary in persistent hypotension 7

---

Inotropic Agent Infusion Rates

For dobutamine infusion in low cardiac output states, administer 2-20 mcg/kg/min without bolus dosing; for milrinone, give optional bolus of 25-75 mcg/kg over 10-20 minutes followed by 0.375-0.75 mcg/kg/min infusion. 1

Dobutamine Protocol

• Start at 2 mcg/kg/min and titrate up to 20 mcg/kg/min based on hemodynamic response 1
• No bolus dose required 1
• Use with caution in patients with heart rate >100 bpm due to risk of tachycardia and arrhythmias 1

Dopamine Dosing

• Low doses (2-3 mcg/kg/min): stimulates dopaminergic receptors for renal effects 1
• Moderate doses (3-5 mcg/kg/min): inotropic effects via beta-adrenergic stimulation 1
• Higher doses (>5 mcg/kg/min): vasopressor effects via alpha-adrenergic stimulation 1
• Frequently combined with dobutamine at higher dobutamine doses 1

Phosphodiesterase Inhibitors

• Milrinone: 25-75 mcg/kg bolus over 10-20 minutes (optional), then 0.375-0.75 mcg/kg/min infusion 1
• Enoximone: 0.25-0.75 mg/kg bolus, then 1.25-7.5 mcg/kg/min infusion 1
• Effects maintained during concomitant beta-blocker therapy as cellular action is distal to beta-adrenergic receptors 1
• Administer bolus only in patients with well-preserved blood pressure 1

---

Vasodilator Infusion Rates

For nitroglycerin infusion in acute heart failure, start at 10-20 mcg/min and increase by 5-10 mcg/min every 3-5 minutes as needed, with slow titration and frequent blood pressure monitoring to avoid large drops in systolic blood pressure. 1

Nitroglycerin Administration

• Initial dose: 10-20 mcg/min IV 1
• Titration: increase in increments of 5-10 mcg/min every 3-5 minutes 1
• Slow titration with frequent BP measurement required to avoid large drops in systolic BP 1
• Arterial line not routinely required but facilitates titration in borderline pressures 1
• Tachyphylaxis common after 24-48 hours, necessitating incremental dosing 1

Nitroprusside Protocol

• Administer with caution: initial infusion rate 0.3 mcg/kg/min, titrate up to 5 mcg/kg/min 1
• Arterial line recommended for continuous monitoring 1
• Use cautiously in patients with acute coronary syndrome due to risk of abrupt hypotension 1

---

Pediatric Glucose Infusion Rates

For critically ill children, adjust parenteral glucose supply based on weight and illness phase: acute phase 2-4 mg/kg/min (28 days-10 kg), stable phase 4-6 mg/kg/min, and recovery phase 6-10 mg/kg/min. 1

Weight-Based Dosing by Illness Phase

28 days to 10 kg:

• Acute phase: 2-4 mg/kg/min (2.9-5.8 g/kg/day) 1
• Stable phase: 4-6 mg/kg/min (5.8-8.6 g/kg/day) 1
• Recovery phase: 6-10 mg/kg/min (8.6-14 g/kg/day) 1

11-30 kg:

• Acute phase: 1.5-2.5 mg/kg/min (2.2-3.6 g/kg/day) 1
• Stable phase: 2-4 mg/kg/min (2.8-5.8 g/kg/day) 1
• Recovery phase: 3-6 mg/kg/min (4.3-8.6 g/kg/day) 1

>45 kg:

• Acute phase: 0.5-1 mg/kg/min (0.7-1.4 g/kg/day) 1
• Stable phase: 1-2 mg/kg/min (1.4-2.9 g/kg/day) 1
• Recovery phase: 2-3 mg/kg/min (2.9-4.3 g/kg/day) 1

Special Considerations for Neonates

• Newborns <28 days with acute illness (infection/sepsis) should temporarily receive the carbohydrate supply of day 1, guided by blood glucose levels 1

---

Critical Infusion System Considerations

Minimize infusion system dead volume (the reservoir between drug-carrier mixing point and patient's blood) to reduce drug delivery lag time and prevent inadvertent bolus administration when flow rates change. 8

Dead Volume Complications

• Dead volume creates a reservoir of drug that continues delivery even after infusion discontinuation 8
• When dose rate changes, significant lag occurs between intended and actual drug delivery 8
• When multiple drug infusions flow together, a change in any drug flow rate transiently affects delivery rate of all others 8
• Risks are magnified with microinfusion strategies (highly concentrated drugs at low rates) 8

Best Practices

• Use infusion systems with smaller dead volumes when possible 8
• Recognize that obligate fluid administration from multiple infusions can contribute to volume overload in critically ill patients 8
• Ensure continuing education of clinical personnel regarding complexities of drug delivery by infusion 8